Slide 86:

But, if you are a researcher like Dr. Miller, Dr. Plioplys, Dr. Klimas, or in any major university, you are paid by your university to do research that you have received grants for. Now, what we need to do is create the ability through the NIDS Board and MAT so that we can provide funding. So that we can pull into this the kind of expertise that says, ‘OK, what virus is going on in your children; what is happening with their immune system; what do we do to change it’. The difference in that is that if you look at our research establishment, they keep studying little pieces, and little pieces. And, one day they’ll get there. Standing up here right now, it has become all too safe to say to you that if none of what I’m presenting tonight succeeds, then 7 years from now, 10 years from now, you’ll see this happening because eventually our system will get there.

But what we need to do is create something that has never been done before. We need to bring good academic people together, bring good educators together, bring good therapists together and say we have a problem – how do we solve it, not how do we study it.

The NIDS Board was not picked at random. These are researchers who each bring into it a very unique perspective. Again, there are many good researchers in our country, but unless they understand this phenomena or know what they’re trying to do, we would be fishing around for a long time.

Dr. Klimas has worked with the immune system, has worked with the idea of Chronic Fatigue Syndrome for 15+ years. Dr. Bruce Miller is renowned in adult neuroanatomy, neurology. His knowledge of the NeuroSPECT scans, his knowledge of the brain is unbelievable. Dr. Mena may be a major key to everything.

If you’re going to try to bring pharmaceutical companies in to look at your children, your children are always last in line. If you listen to Washington, President Clinton, you’ll hear they are trying to get the companies to look at children. They’ve always been afraid to look at children because children are a major medical liability to deal with. So, if we’re going to get a pharmaceutical company to ask how do we help these children, we’ve got to be able to tell them that we can give them a way to show what an agent does and to validate what it’s doing.

To be frank with you, and again, I hope that this will evolve into something that’s never happened before, Dr. Mena has a database. We are not interested in publishing an article every year for the next 5 or 10 years and having our names in print. Dr. Mena is looking to see if we can set up research centers with, literally, NeuroSPECT scanners around the world. They can be linked by satellite to Chile. They’re read into the database. And we can change clinical medicine objectively, creatively, if done right.

Dr. Plioplys is a pediatric neurologist who was doing studies on the immune system and autism 10 to 15 years ago. If you think I’m frustrated, you should listen to Dr. Plioplys talk, How he has watched money get thrown year after year after year into the same areas with no results. Nobody has really focused it where the problem is.

Project 1999, as alluded to, is our way of trying to say that we want to give all of you a target that we can put together existing expertise, existing technology and create an answer for these children. Along with that is the broader goal that I would like to see us focus educators, speech pathologists, OT people, and PT people who have an interest and the knowledge on the best way to rehabilitate your children - not train an autistic child. How do you rehabilitate your child.

First Previous Next Last Index Home Text

Slide 86 of 88